Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma
Antineoplastic Agents, Phytogenic
Nervous System Neoplasms
In heavily treated patients, the regimen studied was well tolerated, allowed patients to continue most normal life activities, and produced anti-NB effects. Its modest toxicity supported use with other antitumor agents.